Qdenga Vaccine
Eligibility Criteria for the Qdenga Vaccine
Eligible | Not Eligible |
Patients aged 18 and above |
|
Note: Your personal information (Full Name, IC/Passport Number, Date of Birth, Residential Postcode, and Vaccination location) will be recorded in the Acts2Care registry in compliance with the Ministry of Health (MOH) requirements.
What Will You Get
2 (two) doses of the Qdenga vaccine. The vaccine is administered as a subcutaneous injection with a three-month gap between doses.
ONE Vaccine for FOUR Virus Strains
The Qdenga vaccine provides protection against four different strains of the dengue virus: DENV-1, DENV-2, DENV-3, and DENV-4.
Potential Side Effect
Side effects from the Qdenga vaccine are usually mild to moderate and typically occur within 2 days of the injection, lasting 1 to 3 days. These effects tend to be less common after the second dose.
- Pain at the injection site
- Headache
- Muscle Pain (Myalgia)
- Redness at the injection site (Erythema)
- General discomfort (Malaise)
- Weakness (Asthenia)
- 发烧
This package is non-refundable unless a **severe allergic reaction occurs after the 1st dose, subject to:
- **Symptoms include swelling (facial/oral), difficulty breathing, throat tingling/swelling sensation, or severe vomiting.
- Doctor consultation to decide if the 2nd dose is advisable.
Am I eligible for the vaccine if I’ve previously had a dengue infection?
Yes, you are eligible to take the vaccine even after a prior dengue infection. However, the CDC advises waiting at least six months after recovering from the infection before getting vaccinated.
Is it safe to receive the Qdenga vaccine during chemotherapy?
The Qdenga vaccine is not recommended during chemotherapy due to the weakened state of the immune system. Currently, there is no established guideline on the ideal interval between chemotherapy and vaccination. It is important to consult your doctor to assess your specific condition and determine the safest timing for the vaccine.